Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ardent Health (ARDT) EBITDA Margin (2023 - 2025)

Ardent Health (ARDT) has 3 years of EBITDA Margin data on record, last reported at 17.64% in Q3 2025.

  • For Q3 2025, EBITDA Margin fell 420.0% year-over-year to 17.64%; the TTM value through Sep 2025 reached 1.01%, up 1030.0%, while the annual FY2024 figure was 2.23%, 332.0% up from the prior year.
  • EBITDA Margin reached 17.64% in Q3 2025 per ARDT's latest filing, down from 2.53% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 27.4% in Q4 2024 and bottomed at 462.81% in Q2 2023.
  • Average EBITDA Margin over 3 years is 55.17%, with a median of 7.49% recorded in 2023.
  • Peak YoY movement for EBITDA Margin: surged 46056bps in 2024, then plummeted -420bps in 2025.
  • A 3-year view of EBITDA Margin shows it stood at 7.49% in 2023, then skyrocketed by 466bps to 27.4% in 2024, then crashed by -164bps to 17.64% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 17.64% in Q3 2025, 2.53% in Q2 2025, and 3.78% in Q1 2025.